Esomeprazole magnesium (Nexium)
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Heartburn
Conditions
Heartburn
Trial Timeline
Nov 1, 2004 → Jul 1, 2005
NCT ID
NCT00206024About Esomeprazole magnesium (Nexium)
Esomeprazole magnesium (Nexium) is a approved stage product being developed by AstraZeneca for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00206024. Target conditions include Heartburn.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00206024 | Approved | Completed |
| NCT00079833 | Phase 3 | Completed |
Competing Products
20 competing products in Heartburn